 | • レポートコード：MRC2305A136 • 出版社/出版日：Transparency Market Research / 2023年3月3日 • レポート形態：英文、PDF、157ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：製薬 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界のペニシリンGアシラーゼ市場規模が、2023年の672.5百万ドルから2031年には11億ドルまで年平均5.6%成長すると見込まれています。本資料はペニシリンGアシラーゼの世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、由来別（E.大腸菌、巨大菌、その他）分析、用途別（半合成ペニシリン生産、半合成セファロスポリン生産、その他）分析、エンドユーザー別（製薬会社、学術&研究機関、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、Merck KGaA (Sigma Aldrich)、Fermenta Biotech Ltd.、Biosynth、Amicogen、Creative Enzymes、Crawford Wisdom International、MuseChem Chemicalsなどの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界のペニシリンGアシラーゼ市場規模：由来別 - E.大腸菌の市場規模 - 巨大菌の市場規模 - その他由来の市場規模 ・世界のペニシリンGアシラーゼ市場規模：用途別 - 半合成ペニシリン生産における市場規模 - 半合成セファロスポリン生産における市場規模 - その他用途における市場規模 ・世界のペニシリンGアシラーゼ市場規模：エンドユーザー別 - 製薬会社における市場規模 - 学術&研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のペニシリンGアシラーゼ市場規模：地域別 - 北米のペニシリンGアシラーゼ市場規模 - 中南米のペニシリンGアシラーゼ市場規模 - ヨーロッパのペニシリンGアシラーゼ市場規模 - アジア太平洋のペニシリンGアシラーゼ市場規模 - 中東・アフリカのペニシリンGアシラーゼ市場規模 ・競争状況 ・企業情報 ・主要ポイント |
Penicillin G Acylase Market – Scope of Report
TMR’s report on the global penicillin G acylase market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global penicillin G acylase market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global penicillin G acylase market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the penicillin G acylase market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global penicillin G acylase market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global penicillin G acylase market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global penicillin G acylase market.
The report delves into the competitive landscape of the global penicillin G acylase market. Key players operating in the global penicillin G acylase market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global penicillin G acylase market profiled in this report.
Key Questions Answered in Global Penicillin G Acylase Market Report
• What is the sales/revenue generated by penicillin G acylase across all regions during the forecast period?
• What are the opportunities in the global penicillin G acylase market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Penicillin G Acylase Market – Research Objectives and Research Approach
The comprehensive report on the global penicillin G acylase market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global penicillin G acylase market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global penicillin G acylase market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Penicillin G Acylase Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Penicillin G Acylase Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Penicillin G Acylase Preform and Immobilize form: An Overview
5.2. Regulatory Scenario by Region/globally
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Penicillin G Acylase Market Analysis and Forecast, By Source
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Source, 2017–2031
6.3.1. E. coli
6.3.2. Bacillus Megaterium
6.3.3. Others
6.4. Market Attractiveness Analysis, By Source
7. Global Penicillin G Acylase Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Production of Semisynthetic Penicillin
7.3.2. Production of Semisynthetic Cephalosporin
7.3.3. Others
7.4. Market Attractiveness Analysis, By Application
8. Global Penicillin G Acylase Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharmaceutical Companies
8.3.2. Academic & Research Institutes
8.3.3. Others
8.4. Market Attractiveness Analysis, By End-user
9. Global Penicillin G Acylase Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Region
10. North America Penicillin G Acylase Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Source, 2017–2031
10.2.1. E. coli
10.2.2. Bacillus Megaterium
10.2.3. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Production of Semisynthetic Penicillin
10.3.2. Production of Semisynthetic Cephalosporin
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharmaceutical Companies
10.4.2. Academic & Research Institutes
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Source
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Penicillin G Acylase Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Source, 2017–2031
11.2.1. E. coli
11.2.2. Bacillus Megaterium
11.2.3. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Production of Semisynthetic Penicillin
11.3.2. Production of Semisynthetic Cephalosporin
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharmaceutical Companies
11.4.2. Academic & Research Institutes
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Source
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Penicillin G Acylase Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Source, 2017–2031
12.2.1. E. coli
12.2.2. Bacillus Megaterium
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Production of Semisynthetic Penicillin
12.3.2. Production of Semisynthetic Cephalosporin
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharmaceutical Companies
12.4.2. Academic & Research Institutes
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Source
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Penicillin G Acylase Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Source, 2017–2031
13.2.1. E. coli
13.2.2. Bacillus Megaterium
13.2.3. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Production of Semisynthetic Penicillin
13.3.2. Production of Semisynthetic Cephalosporin
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharmaceutical Companies
13.4.2. Academic & Research Institutes
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Source
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Penicillin G Acylase Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Source, 2017–2031
14.2.1. E. coli
14.2.2. Bacillus Megaterium
14.2.3. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Production of Semisynthetic Penicillin
14.3.2. Production of Semisynthetic Cephalosporin
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharmaceutical Companies
14.4.2. Academic & Research Institutes
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & South Africa
14.6. Market Attractiveness Analysis
14.6.1. By Source
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Merck KGaA (Sigma Aldrich)
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Fermenta Biotech Ltd.
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. Biosynth
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Amicogen
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Creative Enzymes
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Crawford Wisdom International
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. MuseChem Chemicals
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments